Security key
29772L108
Eton Pharmaceuticals, Inc. - Common Stock (ETON)
CUSIP: 29772L108
Q4 2020 13F Holders as of 31 Dec 2020
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 8,725,390
- Total 13F value
- $74,997,463
- Share change
- +1,690,872
- SEC-reported price per share
- $8.13
- Number of holders
- 45
- Value change
- +$13,790,621
- Number of buys
- 35
- Number of sells
- 7
- Shares outstanding
- 26,828,643
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2020
Institutions
45
Top holders
10
ETON full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Eton Pharmaceuticals, Inc. SEC filings
Eton Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29772L108
Recent filing periods:
Ownership snapshot
Top reported holders of ETON - Eton Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
15/15
Latest evidence
30 Sep 2020
13F
Lead comparable stake: 14%
Showing 1-6 of 15 holder rows.
Quick read
Opaleye Management Inc. leads the comparable SEC ownership view at 14%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Opaleye Management Inc.'s linked filing trail.
Comparable ownership
Top 5
Opaleye Management Inc.
14%
BlackRock Finance, Inc.
3.7%
AWM Investment Company, Inc.
2.3%
VANGUARD GROUP INC
2.1%
STATE STREET CORP
0.66%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
Company
|
14%
|
$28,756,000
3,640,000 shares
|
— | 30 Sep 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
3.7%
|
$7,850,000
993,595 shares
|
— | 30 Sep 2020 |
| AWM Investment Company, Inc. |
13F
Company
|
2.3%
|
$4,911,000
621,681 shares
|
— | 30 Sep 2020 |
| VANGUARD GROUP INC |
13F
Company
|
2.1%
|
$4,449,000
563,032 shares
|
— | 30 Sep 2020 |
| STATE STREET CORP |
13F
Company
|
0.66%
|
$1,405,000
177,876 shares
|
— | 30 Sep 2020 |
| NORTHERN TRUST CORP |
13F
Company
|
0.62%
|
$1,310,000
165,678 shares
|
— | 30 Sep 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
45
Shares
8,725,390
Rows available
45
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
38
Q4 2020 holders
45
Holder diff
7
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 value | Q4 2020 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend